Immunochem Therapeutics LLC

Biotechnology company · Auburndale, Massachusetts, United States

Immunochem Therapeutics LLC is a biotechnology company headquartered in Auburndale, Massachusetts, United States. It has received 7 US government small-business research awards (SBIR/STTR) from health agencies, $6.8 million in total, most recently in 2024.

Profile compiled from public records. Is this your company? Request a correction or update

Immunochem Therapeutics at a glance

Typebiotechnology company

HeadquartersAuburndale, Massachusetts, United States

Employees (self-reported, 2024)3

What does Immunochem Therapeutics do?

US government research funding

7 SBIR/STTR small-business research awards from US health agencies, $6.8 million in total (2018 to 2024). NIH funding came from the National Institute on Aging, National Cancer Institute, National Institute of Neurological Disorders and Stroke.

Frequently asked questions about Immunochem Therapeutics

Where is Immunochem Therapeutics headquartered?

Immunochem Therapeutics LLC is headquartered in Auburndale, Massachusetts, United States.

What does Immunochem Therapeutics do?

Immunochem Therapeutics LLC is a biotechnology company.

Similar companies

Advantagene, Inc.Auburndale, Massachusetts, United States
CereVasc, Inc.Auburndale, Massachusetts, United States
Recursion PharmaceuticalsSalt Lake City, Utah, United States
Vericel CorpBurlington, Massachusetts, United States
SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
Adaptive Biotechnologies CorpSeattle, Washington, United States
Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
Cognition Therapeutics IncPurchase, New York, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences